2-Amino-3-benzyl-1-carboxymethyl-3H-benzoimidazol-1-ium

ID: ALA3559468

PubChem CID: 4186380

Max Phase: Preclinical

Molecular Formula: C16H15N3O2

Molecular Weight: 281.32

Molecule Type: Small molecule

This compound is available for customization.

Associated Items:

Names and Identifiers

Canonical SMILES:  Nc1n(Cc2ccccc2)c2ccccc2[n+]1CC(=O)[O-]

Standard InChI:  InChI=1S/C16H15N3O2/c17-16-18(10-12-6-2-1-3-7-12)13-8-4-5-9-14(13)19(16)11-15(20)21/h1-9,17H,10-11H2,(H,20,21)

Standard InChI Key:  GIDZNHVCAQXMGZ-UHFFFAOYSA-N

Molfile:  

     RDKit          2D

 21 23  0  0  0  0  0  0  0  0999 V2000
    4.0407   -7.0650    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    3.2784   -7.3732    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.7535   -6.7276    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    3.9990   -6.2485    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.2034   -6.0361    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.7406   -7.5232    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.9287   -6.7776    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.4862   -7.1400    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.0785   -8.1773    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    5.5279   -6.3152    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    1.4788   -6.0861    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.1777   -7.5982    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    4.5781   -5.6612    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.9868   -5.2405    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.8538   -5.3529    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.6540   -6.1277    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.5659   -4.6531    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.3657   -4.8780    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.2042   -5.4404    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.4039   -4.6531    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.5791   -4.7031    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  2  1  2  0
  3  2  1  0
  4  1  1  0
  5  4  2  0
  6  1  1  0
  7  3  1  0
  8  6  1  0
  9  2  1  0
 10  8  2  0
 11  7  1  0
 12  8  1  0
 13  4  1  0
 14  5  1  0
 15 11  2  0
 16 11  1  0
 17 18  1  0
 18 13  2  0
 19 16  2  0
 20 15  1  0
 21 19  1  0
  3  5  1  0
 14 17  2  0
 21 20  2  0
M  CHG  2   1   1  12  -1
M  END

Alternative Forms

Associated Targets(non-human)

hprK HPr kinase (97 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Biocomponents

Calculated Properties

Molecular Weight: 281.32Molecular Weight (Monoisotopic): 281.1164AlogP: 0.31#Rotatable Bonds: 4
Polar Surface Area: 74.96Molecular Species: ACIDHBA: 4HBD: 1
#RO5 Violations: HBA (Lipinski): 5HBD (Lipinski): 2#RO5 Violations (Lipinski):
CX Acidic pKa: 2.30CX Basic pKa: CX LogP: -1.85CX LogD: -2.08
Aromatic Rings: 3Heavy Atoms: 21QED Weighted: 0.70Np Likeness Score: -0.80

References

1. Ramström H, Bourotte M, Philippe C, Schmitt M, Haiech J, Bourguignon JJ..  (2004)  Heterocyclic bis-cations as starting hits for design of inhibitors of the bifunctional enzyme histidine-containing protein kinase/phosphatase from Bacillus subtilis.,  47  (9): [PMID:15084125] [10.1021/jm021043o]

Source